INTeGRATE
Brief description of study
This study will evaluate whether the Impella 5.5 heart pump can safely support patients with severe heart failure and cardiogenic shock while doctors optimize their recommended heart failure medications. Patients at multiple hospitals will receive the device, and researchers will assess its safety and feasibility in real-world clinical use. The clinical intervention is the population group HFrEF
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or